Revenue, 2023 (US$M)
$0.0
Forecast, 2030 (US$M)
$0.0
CAGR, 2024 - 2030
-100%
Report Coverage
Mexico

Mexico hormonal contraceptive market highlights

  • An overview of the Mexico hormonal contraceptive market trends heading towards 2030. The market in Mexico generated a revenue of USD 366.6 million in 2022 and is expected to reach USD 482.7 million by 2030.
  • The overall growth of the Mexico market from 2022 to 2030. The Mexico market is expected to grow at a CAGR of 3.5% from 2023 to 2030.
  • A look at the Mexico market revenues per segment in 2022. In terms of segment, iud was the largest revenue generating method in 2022.
  • The segment witnessing the fastest revenue growth within the market. Pill is the most lucrative method segment registering the fastest growth during the forecast period.

Hormonal contraceptive market data book summary

Market revenue in 2022USD 366.6 million
Market revenue in 2030USD 482.7 million
Growth rate3.5% (CAGR from 2022 to 2030)
Largest segmentIud
Fastest growing segmentPill
Historical data2018 - 2021
Base year2022
Forecast period2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPill, IUD, Injectable, Vaginal Ring, Implant, Patch
Key market players worldwideAbbVie Inc, Teva Pharmaceutical Industries Ltd, Bayer AG, Organon & Co Ordinary Shares, Pfizer Inc, Agile Therapeutics Inc, Johnson & Johnson, Lupin, Pregna International, Afaxys

Other key industry trends

  • In terms of revenue, Mexico accounted for 2.1% of the global hormonal contraceptive market in 2022.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Latin America, Brazil hormonal contraceptive market is projected to lead the regional market in terms of revenue in 2030.
  • Brazil is the fastest growing regional market in Latin America and is projected to reach USD 838.3 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Hormonal Contraceptive Market Companies

Name Profile # Employees HQ Website

Mexico hormonal contraceptive market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hormonal contraceptive market will help companies and investors design strategic landscapes.


Iud was the largest segment with a revenue share of 53% in 2023. Horizon Databook has segmented the Mexico hormonal contraceptive market based on pill, iud, injectable, vaginal ring, implant, patch covering the revenue growth of each sub-segment from 2018 to 2030.


  • Mexico Hormonal Contraceptive Method Outlook (Revenue, USD Million, 2018-2030)
    • Pill
    • IUD
    • Injectable
    • Vaginal Ring
    • Implant
    • Patch
  • Mexico Hormonal Contraceptive Hormone Outlook (Revenue, USD Million, 2018-2030)
    • Combined Hormone Contraceptive
    • Progestine Only

Reasons to subscribe to Mexico hormonal contraceptive market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Mexico hormonal contraceptive market databook

  • Our clientele includes a mix of hormonal contraceptive market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Mexico hormonal contraceptive market , including forecasts for subscribers. This country databook contains high-level insights into Mexico hormonal contraceptive market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Mexico Hormonal Contraceptive Market Outlook Share, 2023 & 2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more